Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer

Go back to Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer
(NASDAQ: RNAZ) Delayed: 1.65 -0.07 (4.07%)
Previous Close $1.72    52 Week High
Open $2.00    52 Week Low
Day High $2.00    P/E N/A 
Day Low $1.65    EPS
Volume 30,904